Cargando…
Modulating microRNAs as Novel Therapeutic Targets in Cardiac Fibrosis
This commentary highlights the findings by Tao et al. (Theranostics 2016; 6: 2068-2083) that targeting miR-433 may be a potential therapeutic strategy for myocardial fibrosis and subsequently discusses the obstacles and prospects associated with the application of therapeutic microRNAs in anti-fibro...
Autores principales: | Chen, Zhongxiu, Li, Yajiao, Dian, Ke, Rao, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505060/ https://www.ncbi.nlm.nih.gov/pubmed/28740551 http://dx.doi.org/10.7150/thno.19286 |
Ejemplares similares
-
MicroRNAs in acute myocardial infarction: Evident value as novel biomarkers?
por: Chen, Zhongxiu, et al.
Publicado: (2018) -
MicroRNAs and senescence
por: Martinez, Ivan, et al.
Publicado: (2011) -
microRNAs in viral oncogenesis
por: Scaria, Vinod, et al.
Publicado: (2007) -
MicroRNAs that interfere with RNAi
por: Massirer, Katlin B., et al.
Publicado: (2013) -
MicroRNAs: regulators of oncogenesis and stemness
por: Papagiannakopoulos, Thales, et al.
Publicado: (2008)